1. Eli Lilly and Company
2. Pfizer Inc.
3. F. Hoffmann-La Roche
4. Teva Pharmaceutical Industries Ltd.
5. GlaxoSmithKline plc.
6. Novartis International AG
7. Merck & Co. Inc.
8. Amgen Inc.
Published | Pages | Publisher | Report code |
---|---|---|---|
Feb 2022 | 130 | Renub Research | ASDR-597018 |
1. Eli Lilly and Company
2. Pfizer Inc.
3. F. Hoffmann-La Roche
4. Teva Pharmaceutical Industries Ltd.
5. GlaxoSmithKline plc.
6. Novartis International AG
7. Merck & Co. Inc.
8. Amgen Inc.